Neuroblastoma: Molecular Mechanisms and Novel Treatment Strategies
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".
Deadline for manuscript submissions: closed (20 March 2025) | Viewed by 466
Special Issue Editor
Interests: cancer therapy; histone modification enzymes; histone modification enzyme inhibitors; long noncoding RNA
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce a Call for Papers for manuscripts on “Neuroblastoma: Molecular Mechanisms and Novel Treatment Strategies”. Neuroblastoma, a pediatric malignancy, continues to present significant challenges due to its complex genetic and epigenetic landscape, high-risk classifications, and poor survival outcomes in relapsed cases. Understanding the underlying molecular mechanisms is crucial for developing more effective and targeted therapies.
We invite original research articles and reviews that explore innovative approaches for understanding the biology of neuroblastoma and novel treatment strategies. Topics of interest include, but are not limited to, targeted therapies (e.g., against MYCN), immunotherapies, and epigenetic interventions. Studies focusing on drug resistance mechanisms, biomarkers for personalized medicine, and emerging treatment strategies are welcome.
This Special Issue encourages researchers to contribute high-quality manuscripts that advance our knowledge in the field and provide new insights for combating neuroblastoma. Submissions will undergo peer review to ensure scientific rigor and impact.
Prof. Dr. Tao Liu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- neuroblastoma
- tumorigenesis
- biomarkers
- drug discovery
- experimental therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
